Home › Hyperlipoproteinemia Type II › NCT06439654
Atlantic Lipid Lowering Treatment Optimization Program
Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias
Who can join
Ages 18 to 120 · All sexes
Full eligibility criteria
Inclusion Criteria: * LDL-C ≥160 mg/dL * Untreated LDL-C ≥190 with family history of CAD * Prior MI and currently without optimized lipid-lowering therapy * Family history of CAD in first degree relative * Personal history of CAD * Untreated triglycerides \>500 * Elevated Lp(a) and/or high calcium scores * Consenting individuals Exclusion Criteria: * Individuals who are pregnant * Individuals who are incarcerated * Individuals with a terminal illness * Individuals who do not consent
About the study
Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.
What is being tested
- Supportive care (other)
Sponsor: Atlantic Health System · Participants: 250 · Started: Jul 1, 2024
Contact the study team
- Robert D Fishberg, MD · Phone: 973-467-0005
- Jeffrey N Feldman, MD · Phone: 908-686-9330
Official record on ClinicalTrials.gov — NCT06439654
Locations in the U.S.
| New Jersey | Atlantic Medical Group, Clark (Not yet recruiting) Atlantic Medical Group, Springfield |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.